Excelsior Medical Co., Ltd. · TWSE:4104

Excelsior Medical — Q3 2025 Earnings Presentation

19 slides from Excelsior Medical's earnings presentation, Nov 24, 2025

  1. Slide 1: Excelsior Medical Co., Ltd. Investor Conference

    Excelsior Medical Co., Ltd. Investor Conference 2025/11/24

  2. Slide 2: Disclaimer

    Disclaimer This presentation is prepared according to the audited or reviewed financial statements by CPA and the financial figures hereby are based on IFRS, please refer to the published financial statements for full content. The presentation may contain forward-looking information and may differ m

  3. Slide 3: The Business Types

    The Business Types Hemodialysis Aesthetic Medical Trading Business Medical Devices Medical Consumables Home Appliances Product Planning Sales Information Analysis Promotion Hemodialysis channel Pharma. Sales and Promotion Market Creative Aesthetic Medical channel Pharma. Distribution and Logistics M

  4. Slide 4: Revenue Overview

    Revenue Overview Excelsior yearly consolidated sales is more than NT $ 8.5 billion in 2024, the primary revenue comes from Excelsior (Hemodialysis), Dynamic (Aesthetic Medical), Arich (Pharmaceutical Logistics) and others. According to the company’s function, the business type can be characterized a

  5. Slide 5: Operating Overview

    Operating Overview Unit: NTD in thousands 5

  6. Slide 6: Investment Overview

    Investment Overview Unit: NTD in thousands 6

  7. Slide 7: Profit after Tax Overview

    Profit after Tax Overview Unit: NTD in thousands/ EPS: NTD in Dollars 7

  8. Slide 8: Balance Sheet

    Balance Sheet Unit: In thousands NTD Current Assets: Cash and cash equivalents 2,614,786 4,189,204 2,424,114 Receivables 1,961,336 1,945,932 1,991,094 Other receivables 3,853,342 3,661,059 3,702,421 Inventories 1,247,430 1,392,801 1,363,161 Other current assets 1,014,936 1,031,944 944,385 Total Curr

  9. Slide 9: Balance Sheet

    Balance Sheet 1,134,887 917531 1,122,473 974,726 978,970 1004524 3,464 888 5,307,260 3,264,171 1,104,256 1084891 1,017,659 6.678.757 8,288,661 6,408,827 : 350,000 486,200 721,987 727,939 488,200 721,987 1,077,939 7,166,966 9,010,648 7.486 766 1 856,187 1633975 1.715674 3.287.576 3,382,788 3,382,850

  10. Slide 10: Statement of Comprehensive Income

    Statement of Comprehensive Income Note1:163,398 thousand common shares Note2:171,567 thousand common shares 10

  11. Slide 11: Statements of Cash Flows

    ee Excelsior Healtheare Group a+ Statements of Cash Flows |Unit:In thousands NID —“~‘“S*~*~*~*YSCSC“‘iéiOS S| 0S] 202503 1,144,080 1,174,362 902,541 |Adjustments Cid (164,775) (99,191) (122,949) | Cash Flows from Operating Activities == (244,183) 16,289 (6,683) (542,241) 199,157 (43,995) (139,988) (

  12. Slide 12: Cash Flows from Investing Activities

    Unit: In thousands NTD 2023 2024 2025 Q3 Acquisition of financial assets at fair value through - 1,738 (3,257) profit or loss Proceeds from disposal of financial assets at fair (685) - 1,673 value through profit or loss Acquisition of financial assets at fair value through - (2,387) (838) other comp

  13. Slide 13: Cash Flows from Financing Activities

    Unit: In thousands NTD 2023 2024 2025 Q3 Cash Flows from Financing Activities Increase (decrease) in short- term borrowings 599,753 (217,356) 204,942 Increase in long- term borrowings - - 350,000 Cash dividends paid (540,953) (591,344) (620,910) Proceeds from disposal of ownership interests in 47,73

  14. Slide 14: Sustainability Report

    =e8 Excelsior Healtheare Group FT) (es (ee gs 2024 KR Sustainability Report A eS Dh RRS EM LBM BIAS) sO 14064-1:2018 Sustainability Report y a AAI000 Licensed Report (000-250/V2-J628U eA WW): 14

  15. Slide 15: Concrete ESG Implementation Results

    Concrete ESG Implementation Results 1.In 2023, our company successfully completed the ISO 14064-1 GHG inventory and assurance status ahead of schedule. We will continue to promote the completion of GHG inventories across all subsidiaries within the group. 2.In 2023, our company implemented a smart e

  16. Slide 16: Concrete ESG Implementation Results

    Concrete ESG Implementation Results 1.In 2023, we visited Taipei Zhaoru Senior Care Center to accompany the elderly in a dumpling-making event. In 2024, we organized a Dragon Boat Festival rice dumpling-making activity at Zhongli Smart Aging Academy for seniors with dementia and a recreational event

  17. Slide 17: Concrete ESG Implementation Results

    Concrete ESG Implementation Results 1.In 2022, we published our first Sustainability Report. In 2023, we emphasized SASB (Sustainability Accounting Standards Board) and TCFD (Task Force on Climate-Related Financial Disclosures) standards. 2.In 2023, we established the Sustainability Development Comm

  18. Slide 18: Growing up with Long-term partners

    Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate various professional medical fields. Excelsior will keep taking root in the Asia market, the business scope includes Taiwan, Hong Kong, China

  19. Slide 19: Growing up with Long-term partners

    Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong, China

Excelsior Medical — Q3 2025 Earnings Presentation on 6ix